Objectives: This study was conducted to evaluate the prevalence of cavum septi pellucidi (CSP) enlargement in patients with bipolar disorder (BD) and healthy comparison subjects.: The occurrence of enlarged CSP in patients with BD (n=41, age 35.4±10.8years) and healthy volunteers (n=41, age 35.3±10.0years) was studied using magnetic resonance imaging. The length of the CSP was measured by counting the number of consecutive resliced coronal 0.5-mm images in which the CSP was present. A CSP length ≥6mm was a priori defined as abnormal enlargement of the CSP. Results: Bipolar subjects exhibited a significantly higher prevalence of abnormal CSP enlargement (8 of 41 subjects, 19.5%) than healthy comparison subjects (1 of 41 subjects, 2.4%) (logistic regression analysis: Wald statistic=5.07, df=1, p=0.024). The prevalence of abnormally enlarged CSP was not significantly different between drug-naïve and drug-exposed bipolar subjects or when comparing bipolar I and II sub-diagnoses. Bipolar subjects with abnormal CSP enlargement had a significantly earlier onset of BD than those without (14.3±3.6 versus 20.1±7.4years, respectively). Conclusions: The current study is the first to report an increased prevalence of abnormally enlarged CSP in a well-characterized bipolar population. Our finding that an abnormal enlargement of CSP, a neurodevelopmental abnormality, is associated with early onset of illness implicates early maturational processes as contributing to BD.
- Bipolar disorder
- Cavumsepti pellucidi
- Neuro developmental abnormality